Vascular Endothelial Growth Factor Mouse Recombinant ( VEGF Mouse )

Catalog # PT_42396

Print

$201.00
DescriptionVascular Endothelial Growth Factor Mouse Recombinant produced in E.Coli is a double, non-glycosylated, polypeptide chain containing 165 amino acids and having a molecular mass of 39035 Dalton.The VEGF is purified by proprietary
Product Size: 2ug
Quantity

Data sheet

Formulation
Filtered (0.2um) and lyophilized from a concentrated (1mg/ml) solution in 1PBS, pH7.4.
Solubility
It is recommended to reconstitute the lyophilized Vascular Endothelial Growth Factor in sterile 18M-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.
Purity
Greater than 95.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.
Description
Vascular Endothelial Growth Factor Mouse Recombinant produced in E.Coli is a double, non-glycosylated, polypeptide chain containing 165 (each chain) amino acids and having a molecular mass of 39kDa. The VEGF is purified by proprietary chromatographic tech
Protein Background
Vascular endothelial growth factor is an important signaling protein involved in both vasculogenesis and angiogenesis. As its name implies, VEGF activity has been mostly studied on cells of the vascular endothelium, although it does have effects on a numb
Expression host
Escherichia Coli.
Synonyms
Vascular endothelial growth factor A, VEGF-A, Vascular permeability factor, VPF, VEGF, MGC70609.
Reagent Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Stability
Lyophilized Vascular Endothelial Growth Factor although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution VEGF should be stored at 4°C between 2-7 days and for future use below -18°C.For long term storage
Amino acid sequence
MAPTTEGEQK SHEVIKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC CNDEALECVP TSESNITMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKHCEPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR.
Biological Activity
The biological activity is determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-7.0 ng/ml.
References
Title:VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG.Publication:BMC Physiology 2011, 11:16 doi:10.1186/1472-6793-11-16Link:http://www.biomedcentral.com/1472-6793/11/16/
New